Therefore, by specifically regulating the acetylation level rather than the protein expression level (Figure S2 and S9) of AKR1C1, SIRT2 activation could be a beneficial strategy to inhibit or prevent the AKR1C1-caused metastasis of NSCLC. The gene discussed is SIRT2; the disease is non-small cell lung carcinoma.